Charged Alpha
CHARGED ALPHA · RESEARCH PACKET
Companion to the Q1 FY2027 earnings episode · published October 21,2026

LRCX: Cash Surged — How Much Can Repeat?

Lam Research · Nasdaq: LRCXQuarter ended September 27, 2026Results October 21, 2026 (Time unconfirmed (America/Chicago))Semiconductor equipmentPresented by Hudson & Lana
SELLConviction 2 / 5Uncertainty: High
Fair value (base)$200.00range $135.00–$300.00
Price, Oct 21 close$260.81-23% to base
Probability-weighted$208.75-20% expected

Profit growth is real, but a $1.395 B working-capital swing explains 68.38% of the sequential operating-cash improvement. Our $200 value credits continued expansion without annualizing peak cash. The dated $260.81 price requires a much stronger long-term cash path than our forward case.

Layer 1 · fast

The 60-second read

Revenue$8.219 B+54.4% year over year
GAAP EPS$2.19Adjusted $2.20
Operating margin40.0%GAAP
Operating cash$3.498 BQuarter; includes WC benefit
WC swing$1.395 B68.38% of sequential OCF gain
SimpleFCF$3.240 BAfter capex and intangibles
Net cash$3.702 BRestricted cash excluded
Analytical value$200High uncertainty;2/5 conviction

Five things to know

  1. Growth is broad. Systems and support revenue increased 61.6% and 40.0% year over year.
  2. Cash improved for two reasons. Profit rose and working capital swung by $1.395 Bsequentially.
  3. Guidance execution was solid. Revenue beat the prior midpoint 1.47%; adjustedEPS 2.33%.
  4. The price needs more cash. Reverse year-five cash is $28.17 Bversus our $18 Bforward case.
  5. Disclosure limits remain explicit. Current 10-Q notes and post-print broker revisions are not yet verified.
Layer 1 · the call

Three scenarios, one probability-weighted number

Analyst judgment; not probabilities supplied by management.

Scenario values · USD per share; probabilities are analyst assumptions.
BearBear: $135.00$135.00BaseBase: $200.00$200.00BullBull: $300.00$300.00WeightedWeighted: $208.75$208.75Dated closeDated close: $260.81$260.81
BearBear: $135.00$135.00BaseBase: $200.00$200.00BullBull: $300.00$300.00WeightedWeighted: $208.75$208.75Dated closeDated close: $260.81$260.81
Show the data
MeasureValue
Bear135.00
Base200.00
Bull300.00
Weighted208.75
Dated close260.81
ScenarioProbability12-month valuevs $260.81What has to happenThe arithmetic
Bear25%$135.00−48%Spending slows; cash conversion remains uneven25%×$135=$33.75
Base50%$200.00−23%Growth and normalized cash improve; valuation disciplined50%×$200=$100.00
Bull25%$300.00+15%AI intensity and cash conversion exceed forward case25%×$300=$75.00
Weighted value $208.75 is not the $200 basecase. Range is a scenario framework, not a confidence interval.
Layer 1 · falsifiable

Signposts: what would change our mind

SignpostNow (Q1 FY2027)Green ifRed ifNext check
RevenueSeptember $8.219 BDecember≥$8.60 BDecember<$8.20 BQuarter ending Dec 27,2026
Adjusted EPSSeptember $2.20December≥$2.33December<$2.18Quarter ending Dec 27,2026
Operating marginSeptember 40.2% adjustedDecember≥40.5%December<39.5%Quarter ending Dec 27,2026
Cash conversionQuarter 127.0%Rolling OCF / NI≥100%Rolling OCF / NI<80%Next quarter filing, early 2027
Support growth+0.57% sequentialSequentialgrowth>5%SequentialdeclineNext quarter release, early 2027
Receivable days62.6 endingproxy≤60 days>75 daysNext quarter filing, early 2027
Forwardcash caseYear 5$18 BassumptionEvidencefor>$18 BPathbelow $14 BAnnualreviewFY2027

Numeric thresholds distinguish company guidance from analyst monitoring rules; dates are review windows, not invented release appointments.

The price and the cash question

Lam Research entered this release with a demanding valuation, even after the share price had fallen from its saved yearly high. Our reference is the October 21 regular-session close of $260.81, with a provider timestamp of 20:00:01 UTC. The issuer establishes October 21 as the release date, but the exact release minute has not been established. We therefore do not label the regular-session change an earnings reaction. The saved after-market record contains bid and ask indications rather than an executed last trade; those indications do not replace the reference price or prove a settled market response.

The distinction matters because a good quarter can coexist with a weak share-price response, and a weak tape can reflect positioning rather than deterioration in the business. This packet evaluates the cash a shareholder could eventually receive against the price paid today. It does not infer what investors knew at each minute. Historical observations below compare the first subsequent trading close with the release-date close, where available. They are descriptive windows, not causal estimates, and missing observations remain missing.

The prior quarter's episode centered on record results, strong guidance and an AVOID conclusion. Repeating that framing would obscure what is new. This quarter gives us an unusually informative cash bridge: working capital explains most of the sequential operating-cash improvement, but not all of it. That is neither an accusation that the cash is artificial nor permission to annualize the headline. Our question is how much sustainable cash the growing equipment and installed-service businesses can generate after reinvestment, and how much growth the current price already requires.

TickerNasdaq: LRCX
PeriodQ1 FY2027
Quarter endSep 27,2026
ReleaseOct 21; time unconfirmed
Dated close$260.81
Prior close$263.45
52-week range$135.50–$438.50
Beta1.854 (provider)
Spot shares1,249.145 M
Equity value325,789.5 M
Net cash3,701.9 M
Enterprise value322,087.6 M
TTM simple FCF6,537.4 M
Owner cash yield1.88%
AuditorKPMG current
Votes1/common share
Dated regular-session prices versus analytical value · Saved 15-month daily closes; no claim that October 21 close captures the earnings response. $200 is our analytical value.
$200 analytical value
$0.00$100.00$200.00$300.00$400.00$500.00$200 analytical valueJul 25Sep 25Dec 25Mar 26Jun 26Sep 26$260.81
$0.00$100.00$200.00$300.00$400.00$500.00Jul 25Dec 25Mar 26Jun 26Sep 26$260.81
Show the data
DateClose
2026-10-08320.59
2026-10-09318.84
2026-10-12309.56
2026-10-13301.11
2026-10-14286.92
2026-10-15277.46
2026-10-16263.94
2026-10-19272.20
2026-10-20263.45
2026-10-21260.81
Historical next-session returns · Computed descriptive windows, not causal earnings reactions. Current next session unavailable.
Next close vs release-date close
−1001020Q1 2025 · Next close vs release-date close: 5.1%Q2 2025 · Next close vs release-date close: 7.4%Q3 2025 · Next close vs release-date close: 6.2%Q4 2025 · Next close vs release-date close: −4.3%Q1 2026 · Next close vs release-date close: 4.5%Q2 2026 · Next close vs release-date close: 3.6%Q3 2026 · Next close vs release-date close: −2.6%Q4 2026 · Next close vs release-date close: 18.0%Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
−1001020Q1 2025 · Next close vs release-date close: 5.1%Q2 2025 · Next close vs release-date close: 7.4%Q3 2025 · Next close vs release-date close: 6.2%Q4 2025 · Next close vs release-date close: −4.3%Q1 2026 · Next close vs release-date close: 4.5%Q2 2026 · Next close vs release-date close: 3.6%Q3 2026 · Next close vs release-date close: −2.6%Q4 2026 · Next close vs release-date close: 18.0%Q12025Q22025Q32025Q42025Q12026Q22026Q32026Q42026
Show the data
PeriodNext close vs release-date close
Q1 20255.09
Q2 20257.43
Q3 20256.25
Q4 2025−4.29
Q1 20264.45
Q2 20263.59
Q3 2026−2.63
Q4 202617.98

Strong growth, measured against guidance

September revenue was $8.219 billion, up 54.4% from a year earlier and 22.3% sequentially. GAAP net income reached $2.753 billion, and diluted earnings per share were $2.19. Adjusted earnings were $2.20 per share, a small difference that supports the credibility of the headline improvement. The increase was driven principally by the business, not by an unusually large adjustment or a dramatic reduction in the denominator. Revenue, gross profit and operating profit reconcile directly to the current earnings exhibit, rather than to lagging provider financial statements.

The surprise relative to management's own prior model is more modest than the year-over-year growth rate. July guidance had a revenue midpoint of $8.10 billion and an adjusted EPS midpoint of $2.15. Actual revenue was 1.47% above that midpoint and adjusted EPS was 2.33% above it, both within the published ranges. That is good execution against an already ambitious plan. Calling it a huge guidance beat would confuse the size of the business expansion with the size of the forecast error.

For December, management guides to $8.60 billion of revenue, plus or minus $400 million, and $2.33 of both GAAP and adjusted diluted EPS, plus or minus $0.15. The revenue midpoint implies another 4.63% sequential increase. Gross margin is modeled at 52.5% and operating margin at 40.5%, each with a one-percentage-point tolerance. These are management estimates, not guaranteed orders or our cash-flow forecast. The modeled diluted share count is 1.253 billion. We keep guidance separate from annual consensus and from our valuation assumptions.

MeasureSep 2026Sep 2025Jun 2026
Revenue $M8,219.425,324.176,722.24
Gross profit $M4,298.852,684.883,478.74
Operating income $M3,283.731,829.092,513.49
Net income $M2,753.141,568.662,277.28
GAAP EPS $2.191.241.81
Adjusted EPS $2.201.261.82
OCF $M3,497.651,778.961,457.23
Primary release; calculations in data.json.
Nine quarters of reported revenue · USD millions. Product revenue disaggregation, not separate profit segments.
SystemsSupport and other
02,5005,0007,50010.0KQ1 '25 · Systems: $2,392.7MQ1 '25 · Support and other: $1,775.2MQ2 '25 · Systems: $2,625.6MQ2 '25 · Support and other: $1,750.4MQ3 '25 · Systems: $3,035.3MQ3 '25 · Support and other: $1,684.9MQ4 '25 · Systems: $3,437.6MQ4 '25 · Support and other: $1,733.8MQ1 '26 · Systems: $3,547.6MQ1 '26 · Support and other: $1,776.6MQ2 '26 · Systems: $3,357.5MQ2 '26 · Support and other: $1,987.3MQ3 '26 · Systems: $3,730.6MQ3 '26 · Support and other: $2,110.9MQ4 '26 · Systems: $4,249.8MQ4 '26 · Support and other: $2,472.4MQ1 '27 · Systems: $5,732.9MQ1 '27 · Support and other: $2,486.5MQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
02,5005,0007,50010.0KQ1 '25 · Systems: $2,392.7MQ1 '25 · Support and other: $1,775.2MQ2 '25 · Systems: $2,625.6MQ2 '25 · Support and other: $1,750.4MQ3 '25 · Systems: $3,035.3MQ3 '25 · Support and other: $1,684.9MQ4 '25 · Systems: $3,437.6MQ4 '25 · Support and other: $1,733.8MQ1 '26 · Systems: $3,547.6MQ1 '26 · Support and other: $1,776.6MQ2 '26 · Systems: $3,357.5MQ2 '26 · Support and other: $1,987.3MQ3 '26 · Systems: $3,730.6MQ3 '26 · Support and other: $2,110.9MQ4 '26 · Systems: $4,249.8MQ4 '26 · Support and other: $2,472.4MQ1 '27 · Systems: $5,732.9MQ1 '27 · Support and other: $2,486.5MQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26Q4'26Q1'27
Show the data
PeriodSystemsSupport and other
Q1 '252,392.731,775.25
Q2 '252,625.651,750.40
Q3 '253,035.281,684.90
Q4 '253,437.621,733.77
Q1 '263,547.571,776.61
Q2 '263,357.491,987.30
Q3 '263,730.582,110.91
Q4 '264,249.852,472.39
Q1 '275,732.912,486.51
Guidance testPrior midpointActualNext midpoint
Revenue $M8,1008,219.4188,600
Adjusted EPS $2.152.202.33
Gross margin %52.052.4 adjusted52.5
Operating margin %39.540.2 adjusted40.5
December ranges: revenue±400 M; EPS±0.15; margins±1 percentagepoint.

Equipment, support and geographic exposure

Systems revenue was $5.733 billion, compared with $3.548 billion a year earlier. Customer support-related revenue and other was $2.487 billion, compared with $1.777 billion. Those increases of 61.6% and 40.0% show that the growth is not confined to new equipment. The support category includes services, spares, upgrades and non-leading-edge Reliant equipment. It should not be described as a pure recurring software subscription or as entirely maintenance revenue. The mix contains different buying decisions and different sensitivities to factory utilization.

Sequentially, support-related revenue increased only 0.57%, while systems revenue expanded much more quickly. This makes the current acceleration more dependent on equipment demand and product mix than a casual reading of the support growth rate might suggest. A large installed base provides opportunities for upgrades and spares, but customers can defer projects or change utilization. We would become more confident in durability if support growth and customer cash receipts continued to strengthen after the current systems ramp.

China represented 35% of September revenue, Korea 20%, Taiwan 18%, Japan 9%, the United States 8%, Southeast Asia 6% and Europe 4%. Geography reflects customer facilities, not necessarily the headquarters of the customer or the ultimate consumer of the chips. Export licensing, customer technology transitions and local competition therefore deserve separate analysis. The annual report identifies one reportable business segment comprising aggregated operating segments. Product-line profit is not separately disclosed in the release; we do not assign invented margins to systems or support.

Systems and support: different growth rates · Computed percent growth; support includes Reliant equipment.
SystemsSupport
020406080Year-over-year · Systems: 61.6%Year-over-year · Support: 40.0%Sequential · Systems: 34.9%Sequential · Support: 0.6%Year-over-yearSequential
020406080Year-over-year · Systems: 61.6%Year-over-year · Support: 40.0%Sequential · Systems: 34.9%Sequential · Support: 0.6%Year-over-yearSequential
Show the data
PeriodSystemsSupport
Year-over-year61.6039.96
Sequential34.900.57
September revenue by customer-facility region · Reported percentage of revenue; not customer nationality.
ChinaChina: 35.0%35.0%KoreaKorea: 20.0%20.0%TaiwanTaiwan: 18.0%18.0%JapanJapan: 9.0%9.0%United StatesUnited States: 8.0%8.0%Southeast AsiaSoutheast Asia: 6.0%6.0%EuropeEurope: 4.0%4.0%
ChinaChina: 35.0%35.0%KoreaKorea: 20.0%20.0%TaiwanTaiwan: 18.0%18.0%JapanJapan: 9.0%9.0%United StatesUnited States: 8.0%8.0%Southeast AsiaSoutheast Asia: 6.0%6.0%EuropeEurope: 4.0%4.0%
Show the data
MeasureValue
China35.00
Korea20.00
Taiwan18.00
Japan9.00
United States8.00
Southeast Asia6.00
Europe4.00
Annual reportable-segment profit reconciliation · USD millions; annual reportable-segment measure excludes allocated adjustments. No product-profit estimates.
Segment gross profitConsolidated gross profit
05,00010.0K15.0KFY2024 · Segment gross profit: $7,482.0MFY2024 · Consolidated gross profit: $7,052.8MFY2025 · Segment gross profit: $9,216.0MFY2025 · Consolidated gross profit: $8,979.1MFY2026 · Segment gross profit: $12,120.0MFY2026 · Consolidated gross profit: $11,725.3MFY2024FY2025FY2026
05,00010.0K15.0KFY2024 · Segment gross profit: $7,482.0MFY2024 · Consolidated gross profit: $7,052.8MFY2025 · Segment gross profit: $9,216.0MFY2025 · Consolidated gross profit: $8,979.1MFY2026 · Segment gross profit: $12,120.0MFY2026 · Consolidated gross profit: $11,725.3MFY2024FY2025FY2026
Show the data
PeriodSegment gross profitConsolidated gross profit
FY20247,482.037,052.79
FY20259,216.058,979.06
FY202612,120.0511,725.31

The earnings bridge

Gross profit increased to $4.299 billion and GAAP gross margin reached 52.3%. Research and development of $666.4 million and selling, general and administrative expense of $348.7 million left $3.284 billion of operating income. The operating margin of 40.0% compares with 34.4% a year earlier. This is meaningful operating leverage: revenue expanded faster than the combined expense base. It is not proof that every further dollar of sales will carry the same incremental margin, because mix, procurement, capacity and development spending can change.

Below operating profit, other income was $28.5 million, pretax income was $3.312 billion and the income-tax expense was $559.1 million. Net income therefore reconciles to $2.753 billion. The tiny difference between $2.19 GAAP and $2.20 adjusted EPS should not lead to the claim that all adjustments are trivial in every period. Deferred-compensation asset and liability movements can offset one another, and a tax-law item also appears in this quarter's reconciliation. The full signed rows are retained in the dataset.

The nine-quarter history is split-adjusted. The September 2024 release presented both pre-split and post-split figures around the October 2, 2024 ten-for-one stock split; the comparable series uses its explicitly post-split rows. We also reject provider share counts that substitute a year-to-date or annual weighted average for the quarter's actual diluted average. The valuation denominator is different again: 1,249.145 million shares outstanding at September 27, not the quarter's weighted diluted average and not an unexplained market-cap-derived share estimate.

September operating profit to net income · USD millions; signed tax deduction; primary statement reconciliation.
01,0002,0003,0004,000Operating profit: $3,283.7M$3,283.7MOperatingprofitOther income: $28.5M$28.5MOtherincomePretax profit: $3,312.2M$3,312.2MPretaxprofitTax expense: −$559.1M−$559.1MTax expenseNet income: $2,753.1M$2,753.1MNet income
01,0002,0003,0004,000Operating profit: 3,2843,284OperatingOther income: 2828OtherPretax profit: 3,3123,312PretaxTax expense: −559−559TaxNet income: 2,7532,753Net
Show the data
Step$M
Operating profit3,283.727
Other income28.493
Pretax profit3,312.220
Tax expense−559.082
Net income2,753.138
Split-adjusted EPS across nine quarters · USD per share. September 2024 uses explicitly post-split rows.
GAAP EPSAdjusted EPS
0123Q1 '25 · GAAP EPS: $0.86Q1 '25 · Adjusted EPS: $0.86Q2 '25 · GAAP EPS: $0.92Q2 '25 · Adjusted EPS: $0.91Q3 '25 · GAAP EPS: $1.03Q3 '25 · Adjusted EPS: $1.04Q4 '25 · GAAP EPS: $1.35Q4 '25 · Adjusted EPS: $1.33Q1 '26 · GAAP EPS: $1.24Q1 '26 · Adjusted EPS: $1.26Q2 '26 · GAAP EPS: $1.26Q2 '26 · Adjusted EPS: $1.27Q3 '26 · GAAP EPS: $1.45Q3 '26 · Adjusted EPS: $1.47Q4 '26 · GAAP EPS: $1.81Q4 '26 · Adjusted EPS: $1.82Q1 '27 · GAAP EPS: $2.19Q1 '27 · Adjusted EPS: $2.20Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
0123Q1 '25 · GAAP EPS: $0.86Q1 '25 · Adjusted EPS: $0.86Q2 '25 · GAAP EPS: $0.92Q2 '25 · Adjusted EPS: $0.91Q3 '25 · GAAP EPS: $1.03Q3 '25 · Adjusted EPS: $1.04Q4 '25 · GAAP EPS: $1.35Q4 '25 · Adjusted EPS: $1.33Q1 '26 · GAAP EPS: $1.24Q1 '26 · Adjusted EPS: $1.26Q2 '26 · GAAP EPS: $1.26Q2 '26 · Adjusted EPS: $1.27Q3 '26 · GAAP EPS: $1.45Q3 '26 · Adjusted EPS: $1.47Q4 '26 · GAAP EPS: $1.81Q4 '26 · Adjusted EPS: $1.82Q1 '27 · GAAP EPS: $2.19Q1 '27 · Adjusted EPS: $2.20Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26Q4'26Q1'27
Show the data
PeriodGAAP EPSAdjusted EPS
Q1 '250.860.86
Q2 '250.920.91
Q3 '251.031.04
Q4 '251.351.33
Q1 '261.241.26
Q2 '261.261.27
Q3 '261.451.47
Q4 '261.811.82
Q1 '272.192.20
Diluted weighted-average shares · Millions of shares; valuation instead uses September 27 outstanding 1,249.145 M.
Quarter average
05001,0001,500Q1 '25 · Quarter average: 1,304.1Q2 '25 · Quarter average: 1,291.5Q3 '25 · Quarter average: 1,288.1Q4 '25 · Quarter average: 1,276.9Q1 '26 · Quarter average: 1,269.3Q2 '26 · Quarter average: 1,261.7Q3 '26 · Quarter average: 1,257.3Q4 '26 · Quarter average: 1,256.0Q1 '27 · Quarter average: 1,255.8Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
05001,0001,500Q1 '25 · Quarter average: 1,304.1Q2 '25 · Quarter average: 1,291.5Q3 '25 · Quarter average: 1,288.1Q4 '25 · Quarter average: 1,276.9Q1 '26 · Quarter average: 1,269.3Q2 '26 · Quarter average: 1,261.7Q3 '26 · Quarter average: 1,257.3Q4 '26 · Quarter average: 1,256.0Q1 '27 · Quarter average: 1,255.8Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26Q4'26Q1'27
Show the data
PeriodQuarter average
Q1 '251,304.07
Q2 '251,291.47
Q3 '251,288.10
Q4 '251,276.93
Q1 '261,269.31
Q2 '261,261.74
Q3 '261,257.33
Q4 '261,256.03
Q1 '271,255.77

Nine checks on earnings quality

The quality assessment is constructive on reported earnings and cautious on cash extrapolation. GAAP and adjusted EPS are close. The operating-income bridge balances, and the share-count effect is modest relative to profit growth. Receivables and inventory remain important because equipment can be shipped, installed and accepted on different schedules. Ending-balance days in this packet are simple 91-day diagnostic proxies, not company-reported collection metrics. They should be interpreted alongside growth and customer concentration, not used as proof of a credit problem.

Deferred revenue rose to approximately $2.66 billion from $2.43 billion. The release separately identifies an estimated $468.3 million of future revenue from shipments to Japan for which control has not transferred before customer acceptance. Those shipments remain inventory at cost and are excluded from deferred revenue. Adding the two measures as though both were identical contracted backlog would be misleading. The distinction is useful precisely because different accounting milestones can affect both revenue timing and working capital.

The latest annual report shows four customers at approximately 16%, 15%, 12% and 12% of fiscal 2026 revenue. Five customers represented roughly 20%, 16%, 15%, 11% and 10% of year-end receivables. Concentration is a commercial risk even when counterparties are large and creditworthy: a few capital-budget decisions can move shipments and collections. The current quarter's detailed Form 10-Q was not yet available in the reviewed submissions. We use the earnings exhibit's condensed statements and retain that disclosure limitation instead of inventing updated customer-level notes.

✔ CleanSBC / revenue
1.40%
Economic cost retained; not called free cash.
✔ CleanGAAP→adjusted gap
$0.01 EPS
Small net gap; signed component rows retained.
✔ CleanBelow-the-line items
$28.5 M other income
Small relative to operating profit.
• n/aMinority leak
Not separately shown
No NCI line in condensed release; not an assertion of legal absence.
▲ WatchCash conversion
127.0%
Strong quarter; working-capital swing matters.
▲ WatchReceivable days
62.6 days
Ending balance / quarterly sales ×91 proxy.
▲ WatchInventory days
105.6 days
Ending balance / quarterly cost ×91 proxy.
✔ CleanEffective tax
16.9%
Tax-law adjustment disclosed.
✔ CleanGuidance record
Above midpoints
Revenue+1.47%; adjustedEPS+2.33% versus prior model.
Working-capital day proxies · Computed 91-day ending-balance ratios, not company-reported turnover.
ReceivablesInventory
050100150200Q1 '25 · Receivables: 64Q1 '25 · Inventory: 177Q2 '25 · Receivables: 69Q2 '25 · Inventory: 172Q3 '25 · Receivables: 62Q3 '25 · Inventory: 169Q4 '25 · Receivables: 59Q4 '25 · Inventory: 152Q1 '26 · Receivables: 62Q1 '26 · Inventory: 141Q2 '26 · Receivables: 59Q2 '26 · Inventory: 136Q3 '26 · Receivables: 64Q3 '26 · Inventory: 124Q4 '26 · Receivables: 72Q4 '26 · Inventory: 120Q1 '27 · Receivables: 63Q1 '27 · Inventory: 106Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
050100150200Q1 '25 · Receivables: 64Q1 '25 · Inventory: 177Q2 '25 · Receivables: 69Q2 '25 · Inventory: 172Q3 '25 · Receivables: 62Q3 '25 · Inventory: 169Q4 '25 · Receivables: 59Q4 '25 · Inventory: 152Q1 '26 · Receivables: 62Q1 '26 · Inventory: 141Q2 '26 · Receivables: 59Q2 '26 · Inventory: 136Q3 '26 · Receivables: 64Q3 '26 · Inventory: 124Q4 '26 · Receivables: 72Q4 '26 · Inventory: 120Q1 '27 · Receivables: 63Q1 '27 · Inventory: 106Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26Q4'26Q1'27
Show the data
PeriodReceivablesInventory
Q1 '2564.13176.93
Q2 '2568.73172.20
Q3 '2562.24168.78
Q4 '2559.44151.85
Q1 '2662.10141.19
Q2 '2659.45136.41
Q3 '2664.38124.19
Q4 '2672.28119.97
Q1 '2762.65105.62
Current adjustmentNet income effect $M
Intangible amortization3.016
EDC liability movements13.996
Note discount amortization0.508
EDC asset gain−12.870
Tax benefit on adjustments−0.825
Tax-law expense excluded11.454
Total net adjustment15.279
Primary signed reconciliation. Equity compensation is not automatically the GAAP-to-adjusted gap.

Why cash surged

Operating cash was $3.498 billion, up from $1.457 billion in June. The sequential increase was $2.040 billion. Changes in operating assets and liabilities contributed positive $535.4 million this quarter after consuming $859.9 million in June. The resulting $1.395 billion swing explains 68.38% of the sequential operating-cash improvement. It does not mean that 68% of all current cash is temporary. It means that most of the change between these two particular quarters came from working-capital timing, while profit and other adjustments explain the remainder.

The direct bridge starts with $2.753 billion of net income, adds $122.1 million of depreciation and amortization, subtracts $55.3 million of deferred taxes, adds $114.7 million of equity compensation and $27.6 million of other adjustments, then adds the $535.4 million operating-asset-and-liability contribution. The result matches reported operating cash. Subtracting $257.7 million of capital expenditures and intangible assets gives $3.240 billion of simple free cash flow. We retain the release's combined investment label rather than silently relabeling it as property spending alone.

For an economic owner-cash diagnostic, we also subtract equity compensation and remove the working-capital contribution. That leaves $2.590 billion for the quarter. Multiplying it by four would give $10.359 billion, but that is a diagnostic annualization, not a forecast. It still contains seasonality, taxes, mix and customer acceptance effects. A growing equipment company must fund inventory, receivables and new capacity. The forecast should therefore explain how those requirements evolve instead of treating the strongest recent cash quarter as a permanently distributable annuity.

The annual comparison supplies the counterweight. Fiscal 2026 net income was $7.265 billion, yet operating cash fell to $5.858 billion from $6.173 billion in fiscal 2025. Combined capital expenditures and intangible assets increased to $966.4 million, leaving $4.891 billion of simple free cash flow. Buybacks and dividends totaled $5.122 billion, slightly more than that measure. This is not a solvency warning given the balance sheet, but it shows why an earnings record is not interchangeable with a record of distributable cash. The September rebound must be judged across a longer cycle.

What produced September operating cash · USD millions. Full arithmetic matches the earnings exhibit.
01,0002,0003,0004,000Net income: $2,753.1M$2,753.1MNet incomeDepreciation/amortization: $122.1M$122.1MDepreciation/amortizationDeferred taxes: −$55.3M−$55.3MDeferredtaxesStock compensation: $114.7M$114.7MStockcompensationOther adjustments: $27.6M$27.6MOtheradjustmentsWorking capital: $535.4M$535.4MWorkingcapitalOperating cash: $3,497.7M$3,497.7MOperatingcash
01,0002,0003,0004,000Net income: 2,7532,753NetDepreciation/amortization: 122122D&ADeferred taxes: −55−55TaxStock compensation: 115115SBCOther adjustments: 2828OtherWorking capital: 535535WCOperating cash: 3,4983,498OCF
Show the data
Step$M
Net income2,753.138
Depreciation/amortization122.072
Deferred taxes−55.300
Stock compensation114.696
Other adjustments27.633
Working capital535.413
Operating cash3,497.652
Annual earnings versus cash · USD millions. FCF subtracts capex and intangible assets; it is computed.
Net incomeOperating cashSimple FCF
02,0004,0006,0008,000FY2024 · Net income: $3,827.8MFY2024 · Operating cash: $4,652.3MFY2024 · Simple FCF: $4,255.6MFY2025 · Net income: $5,358.2MFY2025 · Operating cash: $6,173.3MFY2025 · Simple FCF: $5,414.1MFY2026 · Net income: $7,265.4MFY2026 · Operating cash: $5,857.7MFY2026 · Simple FCF: $4,891.3MFY2024FY2025FY2026
02,0004,0006,0008,000FY2024 · Net income: $3,827.8MFY2024 · Operating cash: $4,652.3MFY2024 · Simple FCF: $4,255.6MFY2025 · Net income: $5,358.2MFY2025 · Operating cash: $6,173.3MFY2025 · Simple FCF: $5,414.1MFY2026 · Net income: $7,265.4MFY2026 · Operating cash: $5,857.7MFY2026 · Simple FCF: $4,891.3MFY2024FY2025FY2026
Show the data
PeriodNet incomeOperating cashSimple FCF
FY20243,827.774,652.274,255.60
FY20255,358.226,173.265,414.08
FY20267,265.405,857.664,891.25
Balance / returnSeptember 2026 $MInterpretation
Cash/equivalents7,437.384Restricted cash excluded
Debt + finance leases3,735.444Current plus long-term
Net cash3,701.940Computed equity bridge
Receivables5,658.379Customer collection exposure
Inventory4,550.544Includes Japan shipments pending acceptance
Buyback cash1,024.965Includes excise-tax payments
Dividends paid325.402Different from dividend declared
What the market pays versus balance-sheet cash · USD millions; share price×reported outstanding shares, not provider market-cap share count.
Equity valueEquity value: $325,789.5M$325,789.5MCash equivalentsCash equivalents: $7,437.4M$7,437.4MNet cashNet cash: $3,701.9M$3,701.9M
Equity valueEquity value: $325,789.5M$325,789.5MCash equivalentsCash equivalents: $7,437.4M$7,437.4MNet cashNet cash: $3,701.9M$3,701.9M
Show the data
MeasureValue
Equity value325,789.51
Cash equivalents7,437.38
Net cash3,701.94

Three routes and a distinct reverse case

Our call is SELL, with conviction two out of five and high uncertainty. The analytical fair value is $200, with a broad $135 to $300 scenario range. SELL here describes expected return from the dated $260.81 reference price; it does not deny Lam's operating progress or predict an imminent collapse. The base value is a rounded judgment across three explicit approaches. It is not a claimed market quote, broker target or precise intrinsic-value measurement. A high-quality business can still require an aggressive cash outcome to justify its equity value.

The first route discounts analyst-assumed unlevered operating owner cash of $10, $12, $14, $16 and $18 billion in forecast years one through five, at 10%, with 3% terminal growth. The model includes cash taxes, reinvestment and an economic allowance for stock compensation. These are scenario assumptions, not company guidance. Historical operating cash less investment and stock compensation is an after-interest diagnostic proxy, not an identical definition of forecast enterprise cash flow. We do not mechanically paste the historical proxy into a terminal-value formula without explaining that distinction.

The present value of the five explicit cash years is $51.631 billion and the discounted terminal value is $164.455 billion. Adding $3.702 billion of net cash and dividing by 1,249.145 million outstanding shares gives $175.95 per share. Net cash uses unrestricted cash and equivalents less current and long-term debt and finance-lease obligations. Restricted cash is excluded. The terminal component represents 76.1% of operating value, so small changes in the required return or sustainable growth assumption matter greatly. The sensitivity table is part of the conclusion, not decoration.

The second route capitalizes assumed normalized operating owner cash of $10 billion at 25 times, then adds the same net cash and uses the same share denominator. It produces $203.10 per share. The third applies 24 times an assumed $9.25 of annual EPS, producing $222.00. Both multiples and the EPS assumption are our choices. The EPS assumption is near the current December guidance annualized but is not presented as an annual company forecast. These routes expose the trade-off between a generous multiple and demanding operating delivery; their agreement should not be mistaken for statistical independence.

The reverse case asks a different question from the forward DCF. Starting at $10 billion of first-year operating owner cash, constant growth of approximately 29.55% through year five is required to support $260.81 under the same discount rate, terminal growth, cash and share assumptions. The year-five cash amount would be about $28.17 billion. The forward case instead rises nonuniformly to $18 billion. We keep the two paths visibly distinct: the reverse growth rate is a market-implied test under chosen assumptions, not our forecast or a statement about reported revenue growth.

We assign 25% to a $135 bear case, 50% to a $200 base and 25% to a $300 bull, producing a probability-weighted value of $208.75. These probabilities express judgment, not measured frequencies. The bull requires sustained AI-related equipment intensity, strong utilization of new capacity and better cash conversion than the recent full-year record. The bear allows a spending pause, weaker mix or greater export friction. Even the weighted value remains below the reference price. Evidence that durable owner cash can exceed our trajectory would matter more than a single strong shipment quarter.

1

Forward operating cash DCF

$10/$12/$14/$16/$18B; 10% discount; 3% terminal growth; plus $3.702B net cash; divided by 1,249.145M shares = $175.95/share.

2

Normalized cash multiple

$10B × 25 plus $3.702B net cash; divided by 1,249.145M shares = $203.10/share.

3

Earnings cross-check

Analyst $9.25 EPS × 24 = $222.00/share. Rounded judgment $200; neither EPS nor multiple is company annual guidance.

Forward and reverse cash paths · USD millions. Reverse constant growth 29.55% is distinct from nonuniform forward path.
Forward assumptionReverse to $260.81
010.0K20.0K30.0KYear 1 · Forward assumption: $10,000.0MYear 1 · Reverse to $260.81: $10,000.0MYear 2 · Forward assumption: $12,000.0MYear 2 · Reverse to $260.81: $12,954.9MYear 3 · Forward assumption: $14,000.0MYear 3 · Reverse to $260.81: $16,782.9MYear 4 · Forward assumption: $16,000.0MYear 4 · Reverse to $260.81: $21,742.1MYear 5 · Forward assumption: $18,000.0MYear 5 · Reverse to $260.81: $28,166.6MYear 1Year 2Year 3Year 4Year 5
010.0K20.0K30.0KYear 1 · Forward assumption: $10,000.0MYear 1 · Reverse to $260.81: $10,000.0MYear 2 · Forward assumption: $12,000.0MYear 2 · Reverse to $260.81: $12,954.9MYear 3 · Forward assumption: $14,000.0MYear 3 · Reverse to $260.81: $16,782.9MYear 4 · Forward assumption: $16,000.0MYear 4 · Reverse to $260.81: $21,742.1MYear 5 · Forward assumption: $18,000.0MYear 5 · Reverse to $260.81: $28,166.6MYear1Year2Year3Year4Year5
Show the data
PeriodForward assumptionReverse to $260.81
Year 110,000.0010,000.00
Year 212,000.0012,954.88
Year 314,000.0016,782.90
Year 416,000.0021,742.06
Year 518,000.0028,166.58
DCF sensitivity to discount and terminal growth · USD per share; forward cash path held fixed. Analytical assumptions, not market quotes.
Terminal growth2%3%4%9%$181.96$181.96$206.26$206.26$240.29$240.2910%$158.38$158.38$175.95$175.95$199.39$199.3911%$140.07$140.07$153.26$153.26$170.21$170.2112%$125.46$125.46$135.64$135.64$148.36$148.36Discount rate
Terminal growth2%3%4%9%$181.96$181.96$206.26$206.26$240.29$240.2910%$158.38$158.38$175.95$175.95$199.39$199.3911%$140.07$140.07$153.26$153.26$170.21$170.2112%$125.46$125.46$135.64$135.64$148.36$148.36Rate
Show the data
Discountg 2%g 3%g 4%
9%181.96206.26240.29
10%158.38175.95199.39
11%140.07153.26170.21
12%125.46135.64148.36

Dated Street context

The saved provider consensus target is $376.47, with a $290 low and $500 high. Those numbers are context, not our evidence of post-release analyst revisions. The dated records selected for the comparison are Evercore ISI at $315 on October 20, Deutsche Bank at $375 on October 19, and Morgan Stanley at $385 on October 5. All predate this release. We show the firm and date so viewers can distinguish a published prior view from an analyst response to the September results. No post-print upgrade or downgrade is inferred.

One raw target-news row labels the analyst company Fundamental Research while its headline attributes the target to B. Riley. We exclude that row from firm-specific claims rather than choosing whichever attribution supports a story. Provider annual estimates are likewise a saved snapshot. The fiscal 2027 revenue average is about $35.04 billion and EPS about $9.54; later-year estimates imply continued expansion. They do not establish cash conversion, and analyst counts decline farther into the forecast. We do not call an estimate a reported result or use it to fill an unavailable primary-source field.

The gap between our value and the saved Street target range reflects different assumptions about duration, cash conversion and the multiple investors will pay. It is not resolved by counting recommendations. Our business forecast is already optimistic in absolute terms, with operating owner cash rising to $18 billion. A higher valuation can be coherent if the cash trajectory is much stronger, the required return lower, or terminal growth higher. The useful debate is which of those assumptions the evidence can support, and what would falsify it.

Saved pre-release targets versus our value · USD/share; dated records below. No post-release revision asserted.
Evercore ISIEvercore ISI: $315.00$315.00Deutsche BankDeutsche Bank: $375.00$375.00Morgan StanleyMorgan Stanley: $385.00$385.00Charged AlphaCharged Alpha: $200.00$200.00Dated closeDated close: $260.81$260.81
Evercore ISIEvercore ISI: $315.00$315.00Deutsche BankDeutsche Bank: $375.00$375.00Morgan StanleyMorgan Stanley: $385.00$385.00Charged AlphaCharged Alpha: $200.00$200.00Dated closeDated close: $260.81$260.81
Show the data
MeasureValue
Evercore ISI315.00
Deutsche Bank375.00
Morgan Stanley385.00
Charged Alpha200.00
Dated close260.81
Firm / source recordDateTarget
Evercore ISI2026-10-20315.00
Deutsche Bank2026-10-19375.00
Morgan Stanley2026-10-05385.00
FMP target-news record; attribution mismatch excluded.
Saved annual revenue estimates · USD millions; fiscal years. Saved estimates, not actuals or new revisions.
Provider average
020.0K40.0K60.0K2027 · Provider average: $35,041.5M2028 · Provider average: $42,217.8M2029 · Provider average: $48,177.8M2030 · Provider average: $50,970.7M2031 · Provider average: $55,747.6M20272028202920302031
020.0K40.0K60.0K2027 · Provider average: $35,041.5M2028 · Provider average: $42,217.8M2029 · Provider average: $48,177.8M2030 · Provider average: $50,970.7M2031 · Provider average: $55,747.6M20272028202920302031
Show the data
PeriodProvider average
202735,041.47
202842,217.76
202948,177.81
203050,970.70
203155,747.60
FYRevenue $MEPS $Revenue analystsEPS analysts
202735,041.59.542422
202842,217.812.072017
202948,177.814.32149
203050,970.715.17113
203155,747.617.3064

Execution and capital allocation

Management delivered revenue and adjusted EPS above the July guidance midpoints and within the ranges. That earns credit for near-term forecasting and execution. The next test is whether December revenue and margins land near the new model without an adverse cash-conversion trade-off. Guidance accuracy alone cannot validate a multi-year owner-cash forecast, but repeated delivery at strong margins would reduce one source of uncertainty. Our scorecard therefore separates operating execution, cash conversion, capital allocation and disclosure rather than combining them into a single management compliment.

Capital returns were meaningful: September treasury-stock purchases including excise-tax payments were $1.025 billion and dividends paid were $325.4 million. The declared quarterly dividend rose to $0.33 per common share. Repurchase cash spending, shares retired and the change in shares outstanding are different measures because employee issuance, settlement timing and excise tax intervene. We do not divide cash spending by the net change in shares to invent a purchase price. The annual report's June remaining authorization of $4.043 billion is dated; it is not asserted as September's remaining balance.

The audited annual report identifies KPMG as the current auditor, with Ernst & Young responsible for the earlier audited periods. It also reports approximately 23,300 regular full-time employees as of August 4, 2026, versus 19,000 and 17,450 at the prior dated observations. Those headcount dates do not coincide exactly with quarter ends. Hiring and capacity investment may support growth, but they also add execution commitments. We will judge returns on that expansion through sustainable margins and cash rather than treating employee growth itself as a favorable financial outcome.

TestEvidenceAssessment
GuidanceRevenue and EPS above prior midpointsOperating execution good
Cash conversionFY2026 OCF below earnings; September recoveryImproving but not yet durable
Capital returnsFY2026 $5.122 B versus simpleFCF $4.891 BMonitor funding and price paid
Prior callAVOID 4/5; base $184; price $264.30Current base $200; SELL 2/5
Prior cash triggerCurrent OCF / NI 127.0%; DSO proxy 62.6Direction improved; definitions not assumed identical
NAND/model triggerNo new verified quantitative update in collected releaseUngraded; no manufactured pass
Prior source: saved Q4 FY2026 upload metadata. No prior packet available for identical-scorecard grading.

The saved prior episode used a $184 base value at a $264.30 reference price and an AVOID call with conviction four out of five. Our current $200 value recognizes stronger operating delivery while keeping a skeptical cash test. Current operating-cash conversion is about 127% and the ending receivables proxy is 62.6 days, moving toward the prior stated 100% and 60-day checkpoints. We do not claim an exact like-for-like scorecard because the prior packet is unavailable and its definitions may differ. The prior NAND-conversion and long-term-model triggers remain ungraded without fresh quantitative evidence.

What can break the thesis

The first ranked risk is duration of customer spending. AI demand and increasing device complexity can raise equipment intensity, but a few large customers still control capital budgets and qualification schedules. A delay in a fab or a technology transition can affect both shipments and acceptance. The relevant warning would be a sustained deterioration in systems demand or deferred acceptance alongside weaker cash collection, not merely a volatile share-price day. Our bull case can work without pretending semiconductor equipment has become immune to cycles.

Second is regulatory and geographic exposure. China is 35% of current-quarter revenue, and the annual report explains that export licenses, restricted-entity rules, foreign-direct-product requirements and changing interpretation can constrain sales or customer use. We do not assume that all China revenue is prohibited or that an historical restriction automatically disqualifies the listed parent. The current earnings figures remain analyzable. The risk belongs in the forecast, customer mix and uncertainty range, with any new rule assessed against its actual scope rather than a blanket geographic haircut.

Third is valuation and cash-conversion risk. The market-implied case requires substantially more fifth-year cash than our forward path. If working capital absorbs cash again while equipment growth normalizes, earnings may continue to look attractive before owner cash disappoints. Fourth is product and manufacturing execution: competitive tools, capacity constraints, procurement costs and new-product commercialization can alter margins. Finally, customer concentration magnifies these effects. The risks interact, so adding separate worst-case discounts would double-count some of the same economic exposure.

RankRiskLikelihood / impactEvidence to watch
1Customer capex / acceptanceMedium / highSystems demand and collections
2China / export licensingMedium / highCurrent 35% geographic exposure; actualrule scope
3Valuation / cash conversionHigh / highForward 18 B vs reverse 28.17 Byear fivecash
4Capacity / product executionMedium / highMargins, inventory and customer qualification
5Customer concentrationHigh exposure / medium-high impactFour customers 55% FY2026 revenue

What would change the call

The next December-quarter release is the first operational checkpoint, with its precise announcement date not yet assumed here. We will compare revenue with the $8.20 to $9.00 billion guidance band, adjusted EPS with $2.18 to $2.48, and operating margin with the 39.5% to 41.5% band. Those are company ranges. Our separate cash checkpoints ask whether conversion improves over a rolling window and whether support revenue advances with the installed base. A good result on one metric does not automatically cancel weakness on another.

The forthcoming detailed September Form 10-Q is a disclosure checkpoint. It may explain customer concentration, working-capital movements, commitments or legal matters beyond the condensed release. Until it is available and reviewed, those updates remain unverified. We will also distinguish genuinely new post-release analyst revisions from the pre-release target records already on file. Neither a scheduled earnings call nor a provider calendar timestamp is substituted for the actual earnings-release time.

We would reconsider the SELL judgment if cash conversion supports a materially stronger long-term operating owner-cash path while margins remain resilient, or if price falls enough to offer an adequate return under less demanding assumptions. Conversely, a shortfall in December demand accompanied by receivables or inventory pressure would weaken the base case. These are conditional decision rules, not promises to trade at a particular level. The next packet should grade the signposts against actual results and preserve this dated analysis rather than silently rewriting the earlier call.

CheckpointTimingWhat it resolves
Detailed September 10-QNext filing; date unconfirmedNotes beyond condensedrelease
December quarter endsDecember 27,2026Revenue/margin/workingcapital test
Next earnings releaseExpected early 2027; exact date unconfirmedActual guidance delivery
Post-release target reviewNext source refreshNew vs stale broker views
Capital allocation reviewNext quarterly filingShare count, buyback cost and liquidity

Source record and calculation methods

The dataset retains nine quarterly earnings exhibits, three annual cash-flow observations, full signed income and cash-flow rows, non-GAAP reconciliations, geographic and product revenue, dated market snapshots and every derived calculation. Primary SEC statements control reported figures. FMP provides market history, saved estimates and target records; discrepancies are retained. In particular, current-quarter provider financial statements lagged, and some historical diluted-share fields represented a cumulative average rather than the quarter. We use the actual earnings-release averages for EPS analysis and the reported period-end count for valuation.

Dollar charts use millions unless they are explicitly per share. Share counts are millions. The source statements are in thousands, so the conversion is mechanical. Cash-flow outflows are shown as positive spending when labeled capex, buybacks or dividends; signed original rows remain available. Simple free cash flow means operating cash less capital expenditures and intangible assets. The after-SBC diagnostic also charges equity compensation. Neither measure is a substitute for the company's GAAP statements, and no unavailable product-profit field is estimated merely to complete a table.

The December guidance, pre-release Street records, dated close, analyst scenarios and actual September results are kept separate throughout. The rounded $200 fair value is a judgment informed by the three routes, not a hidden fourth formula. The reverse model is solved independently to the reference price. Missing exact release time, unavailable current detailed notes and unverified post-release broker changes are explicit limitations. This packet was prepared before primary-video and podcast publication; draft links remain empty until the real publication receipts supply them.

QuarterRevenue $MGAAPEPS $AdjEPS $OCF $MSimpleFCF $M
Q1 FY20254,168.00.860.861,568.51,457.9
Q2 FY20254,376.00.920.91741.9553.6
Q3 FY20254,720.21.031.041,308.71,020.6
Q4 FY20255,171.41.351.332,554.22,382.0
Q1 FY20265,324.21.241.261,779.01,593.8
Q2 FY20265,344.81.261.271,480.01,219.2
Q3 FY20265,841.51.451.471,141.4809.8
Q4 FY20266,722.21.811.821,457.21,268.4
Q1 FY20278,219.42.192.203,497.73,240.0
FYOCF $MInvestment $MSBC $MBuybacks $MDividends $MEmployees
20244,652.3396.7293.12,842.81,018.917,450
20256,173.3759.2343.43,422.31,149.519,000
20265,857.7966.4386.43,851.31,270.623,300
Employee observations datedAug 22,2024; Aug 7,2025; Aug 4,2026.